Log in to save to my catalogue

30‐Minute infusion of isatuximab in patients with newly diagnosed multiple myeloma: Results of a Pha...

30‐Minute infusion of isatuximab in patients with newly diagnosed multiple myeloma: Results of a Pha...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6f512f0c1c04412f938e07f19b14f6ba

30‐Minute infusion of isatuximab in patients with newly diagnosed multiple myeloma: Results of a Phase 1b study analysis

About this item

Full title

30‐Minute infusion of isatuximab in patients with newly diagnosed multiple myeloma: Results of a Phase 1b study analysis

Publisher

United States: Lippincott, Williams & Wilkins

Journal title

HemaSphere, 2024-11, Vol.8 (11), p.e70041-n/a

Language

English

Formats

Publication information

Publisher

United States: Lippincott, Williams & Wilkins

More information

Alternative Titles

Full title

30‐Minute infusion of isatuximab in patients with newly diagnosed multiple myeloma: Results of a Phase 1b study analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_6f512f0c1c04412f938e07f19b14f6ba

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6f512f0c1c04412f938e07f19b14f6ba

Other Identifiers

ISSN

2572-9241

E-ISSN

2572-9241

DOI

10.1002/hem3.70041

How to access this item